Causes of end stage renal failure among haemodialysis patients in Khartoum State/Sudan

BMC Research Notes

Mamoun M. Homeida⁴  Khalifa Elmusharaf¹  Rasha A. Babiker³  Mohamed O. Khojali⁵  Sara B. Elbashir⁵  Diana E. Salama⁵  Rania M. Siddig⁵  Elaf B. Mohammed⁵  Amin S. I. Banaga² 

[1]Epidemiology and Public Health, Faculty of Medicine, Royal College of Surgeon in Ireland RCSI Bahrain, Adliya, Bahrain

[2]Haemodialysis Unit, Department of Medicine and Nephrology, University of Medical Sciences and Technology, Academy Charity Teaching Hospital, Khartoum, Sudan

[3]Department of Basic Sciences, Faculty of Medicine, University of Medical Sciences and Technology, Khartoum, Sudan

[4]Department of Medicine, Faculty of Medicine, University of Medical Sciences and Technology, Khartoum, Sudan

[5]Department of Nephrology, Academy Charity Teaching Hospital, Khartoum, Sudan

关键词: Glomerulonephritis;    Diabetes;    Hypertension;    End stage renal failure;    Khartoum;    Sudan;   

Others  :  1229931
DOI  :  10.1186/s13104-015-1509-x

 received in 2015-01-15, accepted in 2015-09-21,  发布年份 2015

【 摘 要 】

Background

End stage renal failure (ESRF) has become a major health problem in Sub Saharan Africa (SSA). There were limited data about causes of ESRF in the Sudan.

Methods

This is a cross sectional hospital based descriptive study. The subjects of the study are ESRF adults’ patients on regular haemodialysis treatment in 15 haemdoialysis centres in Khartoum State—Sudan. Clinical and epidemiological data were obtained from 1583 patients. The medical files of each patient were reviewed to identify the cause of ESRF. Concerning the causes of ESRF, diabetes was diagnosed based on the past medical history and result of the glucose tolerance test, hypertension was diagnosed based on past history of hypertension based on blood pressure of more than 140/90 mmHg, glomerulonephritis was diagnosed based on results of previous kidney biopsies and on clinical grounds, polycystic kidney disease and obstructive uropathy were diagnosed based on abdominal ultrasound and other imaging modalities, sickle cell anaemia was diagnosed based on the result of haemoglobin electrophoresis, systemic lupus erythematosus was diagnosed based on the clinical criteria in addition to lab results of auto antibodies, and analgesic nephropathy was diagnosed based on past medical history of chronic analgesic drugs usage with no other identifiable risk factors. We included all ESRF patients on regular haemodialysis treatment. We excluded ESRF patients less than 18 years old.

Results

The results showed that the mean age of ESRF Patients was 49 ± 15.8 (years) and 63.4 % were male and 76.3 % were unemployed. The mean duration of haemodialysis is 4.38 ± 4.24 (years). The most common cause of ESRF in our patients was hypertension (34.6 %) followed by chronic glomerulonephritis (17.6 %), diabetes mellitus (12.8 %), obstructive uropathy (9.6 %), autosomal dominant poly cystic kidney disease (ADPKD) (4.7 %), chronic pyelonephritis (4.6 %), analgesic nephropathy (3.5 %). However in (10.7 %) no cause was found. In patient aged less than 40 years old the leading cause of ESRF was glomerulonephritis (29.3 %) followed by hypertension (25 %). In patient aged between 40 to 60 years old the leading cause of ESRF was hypertension (38.5 %) followed by diabetes mellitus (14 %). In patient aged older than 60 years the leading cause of ESRF was hypertension (38.4 %) followed by diabetes mellitus (23.3 %).

Conclusions

ESRF in Sudan affects the economically productive age group; unemployment rate among ESRF patients is high. The study showed that hypertension is a leading cause of ESRF in Sudan followed by chronic glomerulonephritis. Hypertension and diabetes mellitus are the leading causes of ESRF among patients over 40 years old.

【 授权许可】

   
2015 Banaga et al.

【 参考文献 】

• [1]Arogundade F, Sanusi A, Hassan M, Akinsola A: The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in trend? Afr Health Sci. 2011, 11(4):594-601.
• [2]Diouf B, Niang A, Ka E, Badiane M, Moreira DT: Chronical renal failure in one Dakar Hospital Department. Dakar Med 2003, 48(3):185-188.
• [3]Plange-Rhule J, Phillips R, Acheampong J, Saggar-Malik A, Cappuccio F, Eastwood J: Hypertension and renal failure in Kumasi, Ghana. J Hum Hypertens 1999, 13(1):37-40.
• [4]Diouf B, Ka E, Niang A, Diouf M, Mbengue M, Diop T: Etiologies of chronic renal insufficiency in a adult internal medicine service in Dakar. Dakar Med 2000, 45(1):62-65.
• [5]Matekole M, Affram K, Lee S, Howie A, Michael J, Adu D: Hypertension and end-stage renal failure in tropical Africa. J Hum Hypertens 1993, 7(5):443-446.
• [6]Du Toit E, Pascoe M, MacGregor K, Thomson P. Combined report on maintenance dialysis and transplantation in the Republic of South Africa. In: South African dialysis and transplantation registry report, ed. Cape Town, South Africa; 1994.
• [7]Diallo A, Niamkey E, Beda YB: Chronic renal insufficiency in Cote d’Ivoire: study of 800 hospital cases. Bull Soc Pathol Exot (1990) 1997, 90(5):346-348.
• [8]Suliman S, Beliela M, Hamza H: Dialysis and transplantation in Sudan. Saudi J Kidney Dis Transplant 1995, 6(3):312.
• [9]Osman E, Abboud O, Danielson B: Chronic renal failure in Khartoum, Sudan. Upsala J Med Sci 1987, 92(1):65-73.
• [10]Abboud O, Osman E, Musa A: The aetiology of chronic renal failure in adult Sudanese patients. Ann Trop Med Parasitol 1989, 83(4):411-414.
• [11]Elsharif M, Elsharif E: Causes of end-stage renal disease in Sudan: a single-center experience. Saudi J Kidney Dis Transplant 2011, 22(2):373.
• [12]Naicker S: End-stage renal disease in sub-Saharan Africa. Ethn Dis 2009, 19(1):13.
• [13]Arogundade FA, Barsoum RS: CKD prevention in Sub-Saharan Africa: a call for governmental, nongovernmental, and community support. Am J Kidney Dis 2008, 51(3):515-523.
• [14]Stel VS, Kramer A, Zoccali C, Jager KJ. The 2007 ERA-EDTA registry annual report—a precis. NDT Plus. 2009:sfp126.
• [15]Shibiru T, Gudina EK, Habte B, Deribew A, Agonafer T: Survival patterns of patients on maintenance hemodialysis for end stage renal disease in Ethiopia: summary of 91 cases. BMC Nephrol 2013, 14(1):127. BioMed Central Full Text
• [16]Ackoundou-N’Guessan K, Lagou D, Tia M, Gnionsahe D, Guei M: Risk factors for chronic renal failure in Ivory coast: a prospective study of 280 patients. Saudi J Kidney Dis Transplant 2011, 22(1):185.
• [17]Helanterä I, Haapio M, Koskinen P, Grönhagen-Riska C, Finne P: Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland. Am J Kidney Dis 2012, 59(5):700-706.
• [18]Blake C, Codd MB, Cassidy A, O’Meara YM: Physical function, employment and quality of life in end-stage renal disease. J Nephrol 1999, 13(2):142-149.
• [19]Msyamboza KP, Ngwira B, Dzowela T, Mvula C, Kathyola D, Harries AD, Bowie C: The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One 2011, 6(5):e20316.
• [20]Mondo CK, Otim MA, Akol G, Musoke R, Orem J: The prevalence and distribution of non-communicable diseases and their risk factors in Kasese district, Uganda: cardiovascular topics. Cardiovasc J Afr 2013, 24(3):52-57.
• [21]Oladapo O, Salako L, Sodiq O, Shoyinka K, Adedapo K, Falase A: A prevalence of cardiometabolic risk factors among a rural Yoruba south-western Nigerian population: a population-based survey: cardiovascular topics. Cardiovasc J Afr 2010, 21(1):26-31.
• [22]Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden of undiagnosed hypertension in Sub-Saharan Africa: a systematic review and meta-analysis. Hypertension. 2014. HYPERTENSIONAHA.114.04394.
• [23]Balla SA, Abdalla AA, Elmukashfi TA, Ahmed HA: Hypertension among rural population in four States: Sudan 2012. Global J Health Sci 2014, 6(3):p206.
• [24]Elbagir MN, Eltom MA, Elmahadi EM, Kadam IM, Berne C: A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan. Diabetes Care 1996, 19(10):1126-1128.
• [25]Elbagir M, Eltom M, Elmahadi E, Kadam I, Berne C: A high prevalence of diabetes mellitus and impaired glucose tolerance in the Danagla community in northern Sudan. Diabet Med 1998, 15(2):164-169.
• [26]Cusumano A, Garcia-Garcia G, Di Gioia C, Hermida O, Lavorato C, Carreno CA, Torrico MP, Batista PB, Romao JE, Badal HP, et al.: End-stage renal disease and its treatment in Latin America in the twenty-first century. Ren Fail 2006, 28(8):631-637.
• [27]Fernandes PF, Ellis PA, Roderick PJ, Cairns HS, Hicks JA, Cameron JS: Causes of end-stage renal failure in black patients starting renal replacement therapy. Am J Kidney Dis 2000, 36(2):301-309.
• [28]Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM: Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med 1989, 321(16):1074-1079.
• [29]Naicker S: End-stage renal disease in sub-Saharan and South Africa. Kidney Int 2003, 63:S119-S122.
• [30]Seck SM, Doupa D, Guéye L, Dia CA: Epidemiology of chronic kidney disease in northern region of Senegal: a community-based study in 2012. Pan Afr Med J 2014, 18:307.
• [31]Spuhler O, Zollinger HU: Chronic interstitial nephritis. Zeitschrift fur klinische Medizin 1953, 151(1):1-50.
• [32]Buckalew JRVM, Schey HM: Renal disease from habitual antipyretic analgesic consumption: an assessment of the epidemilogic evidence. Medicine 1986, 65(5):291-303.
• [33]Henrich WL, Agodoa LE, Barrett B, Bennett WM, Blantz RC, Buckalew VM Jr, D’Agati VD, DeBroe ME, Duggin GG, Eknoyan G: Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committe of the National Kidney Foundation. Am J Kidney Dis 1996, 27(1):162-165.
• [34]Sandler DP, Smith JC, Weinberg CR, Buckalew VM Jr, Dennis VW, Blythe WB, Burgess WP: Analgesic use and chronic renal disease. N Engl J Med 1989, 320(19):1238-1243.
• [35]Morlans M, Laporte J, Vidal X, Cabeza D, Stolley P: End-stage renal disease and non-narcotic analgesics: a case–control study. Br J Clin Pharmacol 1990, 30(5):717-723.
• [36]Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994, 331(25):1675-1679.
• [37]Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder C-G, Blot WJ, McLaughlin JK: Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 2001, 345(25):1801-1808.
• [38]Sandler DP, Burr FR, Weinberg CR: Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991, 115(3):1-165.
• [39]Kleinknecht D: Interstitial nephritis, the nephrotic syndrome, and chronic renal failure secondary to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995, 1995:228-235.
• [40]Plantinga L, Grubbs V, Sarkar U, Hsu C-Y, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M: Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med 2011, 9(5):423-430.
• [41]Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Aresté N, de la Torre RA, Caskey F, Couchoud C: Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 2014, 29(suppl 4):iv15-iv25.
• [42]Bourquia A: Autosomal dominant polycystic kidney disease (ADPKD). in Morocco. Multicenter study about 308 families. Nephrologie 2001, 23(2):93-96.
• [43]Alashek WA, McIntyre CW, Taal MW: Epidemiology and aetiology of dialysis-treated end-stage kidney disease in Libya. BMC Nephrol 2012, 13(1):33. BioMed Central Full Text
• [44]Fary Ka E, Seck S, Niang A, Cisse M, Diouf B: Patterns of autosomal dominant polycystic kidney diseases in black Africans. Saudi J Kidney Dis Transplant 2010, 21(1):1-81.
• [45]Ataga KI, Derebail VK, Archer DR: The glomerulopathy of sickle cell disease. Am J Hematol. 2014;89:907–14.
• [46]Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C: Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med 1991, 115(8):614-620.
• [47]Abbott K, Hypolite I, Agodoa L: Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol 2002, 58(1):9-15.
• [48]Afshar R, Sanavi S, Salimi J: Epidemiology of chronic renal failure in Iran: a four year single center experience. Saudi J Kidney Dis Transplant 2007, 18(2):191.
• [49]Madala N, Thusi G, Assounga AG, Naicker S: Characteristics of South African patients presenting with kidney disease in rural KwaZulu-Natal: a cross sectional study. BMC Nephrol 2014, 15(1):61. BioMed Central Full Text